Ignite Creation Date:
2024-05-06 @ 12:20 AM
Last Modification Date:
2024-10-26 @ 10:48 AM
Study NCT ID:
NCT01545336
Status:
COMPLETED
Last Update Posted:
2016-10-27
First Post:
2012-02-29
Brief Title:
Anastrozole in Patients With Pulmonary Arterial Hypertension
Sponsor:
University of Pennsylvania
Organization:
University of Pennsylvania
Study Overview
Official Title:
A Double-blind Placebo-controlled Phase II Study of Anastrozole in Patients With Pulmonary Arterial Hypertension
Status:
COMPLETED
Status Verified Date:
2016-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AIPH
Brief Summary:
The main purpose of this clinical trial is to study the safety and efficacy of anastrozole in adults diagnosed with pulmonary arterial hypertension PAH The study will evaluate how well the drug is tolerated The study will also evaluate if anastrozole effects estradiol E2 hormone levels a sex hormone and improves the function of the lower right chamber of the heart right ventricle
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None